- Home
- BBOT vs AHCO Comparison
BBOT vs AHCO Comparison
Compare BBOT & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBOT | AHCO |
|---|---|---|
| Founded | 2016 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 717.8M | 806.5M |
| IPO Year | 2024 | 2017 |
Fundamental Metrics
Financial Performance| Metric | BBOT | AHCO |
|---|---|---|
| Price | $9.61 | $5.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $24.00 | $13.50 |
| AVG Volume (30 Days) | 254.2K | ★ 3.9M |
| Earning Date | 05-26-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 99.93 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $3,244,857,000.00 |
| Revenue This Year | N/A | $9.00 |
| Revenue Next Year | N/A | $6.93 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.00 | $5.21 |
| 52 Week High | $14.87 | $13.43 |
Technical Indicators
Market Signals| Indicator | BBOT | AHCO |
|---|---|---|
| Relative Strength Index (RSI) | 60.86 | 24.42 |
| Support Level | $7.99 | $5.21 |
| Resistance Level | $11.02 | $10.71 |
| Average True Range (ATR) | 0.48 | 0.41 |
| MACD | 0.02 | -0.14 |
| Stochastic Oscillator | 87.94 | 8.46 |
Price Performance
Historical ComparisonAbout BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.
About AHCO AdaptHealth Corp.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.